JP2018538247A5 - - Google Patents

Download PDF

Info

Publication number
JP2018538247A5
JP2018538247A5 JP2018521137A JP2018521137A JP2018538247A5 JP 2018538247 A5 JP2018538247 A5 JP 2018538247A5 JP 2018521137 A JP2018521137 A JP 2018521137A JP 2018521137 A JP2018521137 A JP 2018521137A JP 2018538247 A5 JP2018538247 A5 JP 2018538247A5
Authority
JP
Japan
Prior art keywords
aml
genes
patient
gene
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018521137A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018538247A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2016/081974 external-priority patent/WO2017069288A1/en
Publication of JP2018538247A publication Critical patent/JP2018538247A/ja
Publication of JP2018538247A5 publication Critical patent/JP2018538247A5/ja
Withdrawn legal-status Critical Current

Links

JP2018521137A 2015-10-23 2016-10-21 Amlを処置することに用いるための医薬組成物およびそれを必要とする対象においてamlを処置する方法 Withdrawn JP2018538247A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562245667P 2015-10-23 2015-10-23
US62/245,667 2015-10-23
PCT/JP2016/081974 WO2017069288A1 (en) 2015-10-23 2016-10-21 Pharmaceutical composition for use in treating aml and method of treating aml in a subject in need thereof

Publications (2)

Publication Number Publication Date
JP2018538247A JP2018538247A (ja) 2018-12-27
JP2018538247A5 true JP2018538247A5 (enExample) 2019-12-19

Family

ID=57349100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018521137A Withdrawn JP2018538247A (ja) 2015-10-23 2016-10-21 Amlを処置することに用いるための医薬組成物およびそれを必要とする対象においてamlを処置する方法

Country Status (8)

Country Link
US (1) US20180303812A1 (enExample)
EP (1) EP3364966A1 (enExample)
JP (1) JP2018538247A (enExample)
KR (1) KR20180067677A (enExample)
CN (1) CN108135884A (enExample)
HK (1) HK1253320A1 (enExample)
TW (1) TW201722428A (enExample)
WO (1) WO2017069288A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
CN109843329A (zh) * 2016-10-17 2019-06-04 第一三共株式会社 使用mdm2抑制剂和dna甲基转移酶抑制剂的组合治疗方法
CN119236065A (zh) * 2018-10-30 2025-01-03 宏观基因有限公司 用于治疗血液系统恶性肿瘤的双特异性CD123 x CD3双抗体
CN111893172A (zh) * 2020-06-24 2020-11-06 南通大学附属医院 Grsf1在判断脓毒症患者严重程度及预后方面的应用
CN115992226B (zh) * 2021-10-19 2024-10-01 上海交通大学医学院附属新华医院 检测c1q表达水平的试剂在制备急性髓细胞白血病诊断或预后判断及治疗试剂中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8392127B2 (en) 2008-03-22 2013-03-05 Merck Sharp & Dohme Corp. Methods and gene expression signature for assessing growth factor signaling pathway regulation status
SI2684880T1 (en) * 2011-03-10 2018-08-31 Daiichi Sankyo Company, Limited DERIVAT DISPIROPYROLIDINE
TWI586668B (zh) * 2012-09-06 2017-06-11 第一三共股份有限公司 二螺吡咯啶衍生物之結晶
EP3094746A1 (en) 2014-01-14 2016-11-23 Daiichi Sankyo Company, Limited Gene signatures associated with sensitivity to mdm2 inhibitors

Similar Documents

Publication Publication Date Title
JP2018538247A5 (enExample)
Funk et al. CSF1R antagonism limits local restimulation of antiviral CD8+ T cells during viral encephalitis
Tsoi et al. Atopic dermatitis is an IL-13–dominant disease with greater molecular heterogeneity compared to psoriasis
Berkun et al. The familial Mediterranean fever gene as a modifier of periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome
Singanayagam et al. A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD
Vandenbroeck et al. A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis
Uyar et al. Single-cell transcriptomics of the ventral posterolateral nucleus-enriched thalamic regions from HSV-1-infected mice reveal a novel microglia/microglia-like transcriptional response
Kenyon et al. The genetic backbone of ankylosing spondylitis: how knowledge of genetic susceptibility informs our understanding and management of disease
Zhao et al. Kynurenine-3-monooxygenase (KMO) broadly inhibits viral infections via triggering NMDAR/Ca2+ influx and CaMKII/IRF3-mediated IFN-β production
Kung et al. Zika virus-induced TNF-α signaling dysregulates expression of neurologic genes associated with psychiatric disorders
Dong et al. Heterogeneity of macrophage activation syndrome and treatment progression
Licastro et al. Variants in antiviral genes are risk factors for cognitive decline and dementia
Fritz-Weltin et al. Acute CNS infections–expanding the spectrum of neurological manifestations of hepatitis E virus?
Wang et al. Excessive apoptosis of Rip1‐deficient T cells leads to premature aging
Cherdyntseva et al. Age-related function of tumor suppressor gene TP53: contribution to cancer risk and progression
Arnold et al. Robust gene expression changes in the ganglia following subclinical reactivation in rhesus macaques infected with simian varicella virus
Peña et al. Multiplexed digital mRNA profiling of the inflammatory response in the West Nile Swiss Webster mouse model
Wang et al. Impact of ABCB1 single-nucleotide polymorphisms on treatment outcomes with salmeterol/fluticasone combination therapy for stable chronic obstructive pulmonary disease
Pangrazzi et al. The interplay between oxidative stress and inflammation supports autistic-related behaviors in mice
Rangel et al. Single-cell and spatiotemporal transcriptomic profiling of brain immune infiltration following Venezuelan equine encephalitis virus infection
Petrova et al. 163 Is diagnostic of Pseudomonas aeruginosa deficient in Bulgarian CF patients?
Shao et al. Interaction Between Childhood Environmental Tobacco Smoke Exposure and IL1RN Variants and Circulating IL1RA in Asthma Risk
Gao et al. Interferon-gamma (IFNG) and IFNGR1 Gene Variants are Associated with Atopic Dermatitis Complicated by Eczema Herpeticum (ADEH) and IFN Production
WO2023239704A2 (en) Preventing alu sines-mediated pathologies
Poovindran Anada et al. A prevalence study of single nucleotide polymorphisms in the promoter of the apolipoprotein E gene in different ethnic groups in Malaysia.